Urinary Tract Infection |
1 |
1 |
Clinician Health and Well-Being |
0 |
0.97 |
Antibiotics |
0 |
0.98 |
Medical Life |
0 |
0.58 |
Recurrent Urinary Tract Infection |
0 |
0.99 |
Pain Management |
0 |
0.29 |
Bladder |
0 |
0.23 |
Nonsteroidal Anti-Inflammatory Agents |
0 |
0.23 |
Overactive Bladder |
0 |
0.17 |
Analgesia |
0 |
0.15 |
Bacteria |
0 |
0.15 |
Dorsum |
0 |
0.15 |
Estrogen |
0 |
0.15 |
Microbiome |
0 |
0.15 |
Probiotics |
0 |
0.15 |
Urinalysis |
0 |
0.15 |
Vagina |
0 |
0.15 |
Complementary and Alternative Medicine |
0 |
0.1 |
Antibiotic Overuse |
0 |
0.96 |
Antibiotic Resistance |
0 |
0.08 |
California |
0 |
0.08 |
Clinical Guidelines |
0 |
0.08 |
Clostridial Infection |
0 |
0.08 |
Health Care Quality, Access, and Evaluation |
0 |
0.95 |
Internet |
0 |
0.08 |
Jobs |
0 |
0.08 |
Outpatient Clinic |
0 |
0.08 |
Overprescribing |
0 |
0.08 |
Pain |
0 |
0.08 |
Quality of Life |
0 |
0.08 |
Travel Medicine |
0 |
0.08 |
Urethra |
0 |
0.08 |
Clostridium Difficile Infection |
0 |
0.05 |
Health Care Reform |
0 |
0.05 |
Social Determinants of Health |
0 |
0.05 |